New statistical models developed by researchers at the Dana-Farber Cancer Institute in Boston suggest that active surveillance may be highly appropriate and lead to better quality of life for men diagnosed with low-risk prostate cancer.

Continue Reading

These models also show a significant cost-savings is associated with active surveillance.

John Schieszer reports in today’s Medical Minute that these models are based on a variety of scenarios, focusing on men ages 65 to 75 at diagnosis.